Global Paediatric Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Oct-2018
No. of pages: 117
Inquire Before Buying

Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins.

The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.

Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.

However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.

In 2017, the global Paediatric Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Paediatric Vaccine market based on company, product type, application and key regions.

This report studies the global market size of Paediatric Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paediatric Vaccine in these regions.

This research report categorizes the global Paediatric Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Paediatric Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Paediatric Vaccine include

- GlaxoSmithCline

- Merck

- Sanofi

- Bristol-Myers Squibb

- Abbott Laboratories

- Eli Lilly

- Pfizer

- F. Hoffmann-La Roche

- Novo Nordisk

Market Size Split by Type

- Pneumococcal

- Varicella

- Combinations

- Poliovirus

- Hepatitis 

- MMR 

- Pediatric Hormones     

- HIB

- Allergy and Respiratory vaccines

- Other Pediatric vaccines

Market Size Split by Application

- Age (0-3)

- Age (3-12)

- Age Above 12

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Paediatric Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Paediatric Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Paediatric Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Paediatric Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Paediatric Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Paediatric Vaccine are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paediatric Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Paediatric Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Paediatric Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Paediatric Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal
1.4.3 Varicella
1.4.4 Combinations
1.4.5 Poliovirus
1.4.6 Hepatitis 
1.4.7 MMR 
1.4.8 Pediatric Hormones     
1.4.9 HIB
1.4.10 Allergy and Respiratory vaccines
1.4.11 Other Pediatric vaccines
1.5 Market by Application
1.5.1 Global Paediatric Vaccine Market Size Growth Rate by Application
1.5.2 Age (0-3)
1.5.3 Age (3-12)
1.5.4 Age Above 12
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Paediatric Vaccine Market Size
2.1.1 Global Paediatric Vaccine Revenue 2016-2025
2.1.2 Global Paediatric Vaccine Sales 2016-2025
2.2 Paediatric Vaccine Growth Rate by Regions
2.2.1 Global Paediatric Vaccine Sales by Regions
2.2.2 Global Paediatric Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Paediatric Vaccine Sales by Manufacturers
3.1.1 Paediatric Vaccine Sales by Manufacturers
3.1.2 Paediatric Vaccine Sales Market Share by Manufacturers
3.1.3 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Paediatric Vaccine Revenue by Manufacturers
3.2.1 Paediatric Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Paediatric Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Paediatric Vaccine Price by Manufacturers
3.4 Paediatric Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Paediatric Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Paediatric Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Paediatric Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Paediatric Vaccine Sales by Type
4.2 Global Paediatric Vaccine Revenue by Type
4.3 Paediatric Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Paediatric Vaccine Breakdown Data by Application
6 North America
6.1 North America Paediatric Vaccine by Countries
6.1.1 North America Paediatric Vaccine Sales by Countries
6.1.2 North America Paediatric Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Paediatric Vaccine by Type
6.3 North America Paediatric Vaccine by Application
6.4 North America Paediatric Vaccine by Company
7 Europe
7.1 Europe Paediatric Vaccine by Countries
7.1.1 Europe Paediatric Vaccine Sales by Countries
7.1.2 Europe Paediatric Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Paediatric Vaccine by Type
7.3 Europe Paediatric Vaccine by Application
7.4 Europe Paediatric Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Paediatric Vaccine by Countries
8.1.1 Asia Pacific Paediatric Vaccine Sales by Countries
8.1.2 Asia Pacific Paediatric Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Paediatric Vaccine by Type
8.3 Asia Pacific Paediatric Vaccine by Application
8.4 Asia Pacific Paediatric Vaccine by Company
9 Central & South America
9.1 Central & South America Paediatric Vaccine by Countries
9.1.1 Central & South America Paediatric Vaccine Sales by Countries
9.1.2 Central & South America Paediatric Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Paediatric Vaccine by Type
9.3 Central & South America Paediatric Vaccine by Application
9.4 Central & South America Paediatric Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Paediatric Vaccine by Countries
10.1.1 Middle East and Africa Paediatric Vaccine Sales by Countries
10.1.2 Middle East and Africa Paediatric Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Paediatric Vaccine by Type
10.3 Middle East and Africa Paediatric Vaccine by Application
10.4 Middle East and Africa Paediatric Vaccine by Company
11 Company Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.1.4 Paediatric Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.2.4 Paediatric Vaccine Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.3.4 Paediatric Vaccine Product Description
11.3.5 Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.4.4 Paediatric Vaccine Product Description
11.4.5 Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.5.4 Paediatric Vaccine Product Description
11.5.5 Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.6.4 Paediatric Vaccine Product Description
11.6.5 Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.7.4 Paediatric Vaccine Product Description
11.7.5 Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.8.4 Paediatric Vaccine Product Description
11.8.5 Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.9.4 Paediatric Vaccine Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Paediatric Vaccine Raw Material
13.1.2 Paediatric Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Paediatric Vaccine
Figure Global Paediatric Vaccine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Paediatric Vaccine Production Market Share by Types (Product Category) in 2017
Figure Pneumococcal Product Picture
Table Major Manufacturers of Pneumococcal
Figure Varicella Product Picture
Table Major Manufacturers of Varicella
Figure Combinations Product Picture
Table Major Manufacturers of Combinations
Figure Poliovirus Product Picture
Table Major Manufacturers of Poliovirus
Figure Hepatitis  Product Picture
Table Major Manufacturers of Hepatitis 
Figure MMR  Product Picture
Table Major Manufacturers of MMR 
Figure Pediatric Hormones      Product Picture
Table Major Manufacturers of Pediatric Hormones     
Figure HIB Product Picture
Table Major Manufacturers of HIB
Figure Allergy and Respiratory vaccines Product Picture
Table Major Manufacturers of Allergy and Respiratory vaccines
Figure Other Pediatric vaccines Product Picture
Table Major Manufacturers of Other Pediatric vaccines
Table Global Paediatric Vaccine Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Age (0-3)
Figure Age (3-12)
Figure Age Above 12
Figure Paediatric Vaccine Report Years Considered
Figure Global Paediatric Vaccine Market Size 2016-2025 (Million US$)
Figure Global Paediatric Vaccine Sales 2016-2025 (K Units)
Table Global Paediatric Vaccine Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Paediatric Vaccine Sales by Regions 2016-2025 (K Units)
Table Global Paediatric Vaccine Sales Market Share by Regions 2016-2025
Figure Global Paediatric Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Paediatric Vaccine Sales Market Share by Regions
Table Global Paediatric Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Paediatric Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Paediatric Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Paediatric Vaccine Revenue Market Share by Regions
Table Global Paediatric Vaccine Sales by Manufacturers (2016-2018) (K Units)
Table Global Paediatric Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Paediatric Vaccine Sales Share by Manufacturers in 2017
Table Paediatric Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Paediatric Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Paediatric Vaccine Value Share by Manufacturers in 2017
Table Global Paediatric Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Paediatric Vaccine Price (2016-2018) (USD/Unit)
Table Paediatric Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Paediatric Vaccine Product Category
Table Date of International Manufacturers Enter into Paediatric Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table Global Paediatric Vaccine Sales Share by Type (2016-2025)
Figure Global Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure Global Paediatric Vaccine Sales Market Share by Type in 2017
Table Global Paediatric Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Paediatric Vaccine Revenue Share by Type (2016-2025)
Figure Global Paediatric Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Paediatric Vaccine Revenue Market Share by Type in 2017
Table Paediatric Vaccine Price by Type 2013-2018 (USD/Unit)
Table Global Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table Global Paediatric Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Paediatric Vaccine Market Share by Application (2016-2025)
Figure Global Sales Paediatric Vaccine Market Share by Application (2016-2025)
Figure North America Paediatric Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure North America Paediatric Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Paediatric Vaccine Sales by Countries (2016-2025) (K Units)
Table North America Paediatric Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Paediatric Vaccine Sales Market Share by Countries
Table North America Paediatric Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Paediatric Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Paediatric Vaccine Revenue Market Share by Countries
Figure United States Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure United States Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Canada Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table North America Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Paediatric Vaccine Market Share by Type
Table North America Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table North America Paediatric Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Paediatric Vaccine Market Share by Application
Table North America Paediatric Vaccine Sales by Company (2016-2018) (K Units)
Table North America Paediatric Vaccine Sales Market Share by Company (2016-2018)
Figure North America Paediatric Vaccine Sales Market Share by Company in 2017
Figure Europe Paediatric Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Europe Paediatric Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Paediatric Vaccine Sales by Countries (2016-2025) (K Units)
Table Europe Paediatric Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Paediatric Vaccine Sales Market Share by Countries
Table Europe Paediatric Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Paediatric Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Paediatric Vaccine Revenue Market Share by Countries
Figure Germany Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Germany Paediatric Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure France Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure France Paediatric Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure UK Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure UK Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Italy Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Russia Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table Europe Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Paediatric Vaccine Market Share by Type
Table Europe Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table Europe Paediatric Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Paediatric Vaccine Market Share by Application
Table Europe Paediatric Vaccine Sales by Company (2016-2018) (K Units)
Table Europe Paediatric Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Paediatric Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Paediatric Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Paediatric Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Paediatric Vaccine Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Paediatric Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Paediatric Vaccine Sales Market Share by Countries
Table Asia Pacific Paediatric Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Paediatric Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Paediatric Vaccine Revenue Market Share by Countries
Figure China Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure China Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Japan Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Korea Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure India Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Australia Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table Asia Pacific Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Paediatric Vaccine Market Share by Type
Table Asia Pacific Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table Asia Pacific Paediatric Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Paediatric Vaccine Market Share by Application
Table Asia Pacific Paediatric Vaccine Sales by Company (2016-2018) (K Units)
Table Asia Pacific Paediatric Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Paediatric Vaccine Sales Market Share by Company in 2017
Figure Central & South America Paediatric Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Paediatric Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Paediatric Vaccine Sales by Countries (2016-2025) (K Units)
Table Central & South America Paediatric Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Paediatric Vaccine Sales Market Share by Countries
Table Central & South America Paediatric Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Paediatric Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Paediatric Vaccine Revenue Market Share by Countries
Figure Brazil Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table Central & South America Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Paediatric Vaccine Market Share by Type
Table Central & South America Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table Central & South America Paediatric Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Paediatric Vaccine Market Share by Application
Table Central & South America Paediatric Vaccine Sales by Company (2016-2018) (K Units)
Table Central & South America Paediatric Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Paediatric Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Paediatric Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Paediatric Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Paediatric Vaccine Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Paediatric Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Paediatric Vaccine Sales Market Share by Countries
Table Middle East and Africa Paediatric Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Paediatric Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Paediatric Vaccine Revenue Market Share by Countries
Figure GCC Countries Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Paediatric Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Paediatric Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Paediatric Vaccine Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Paediatric Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Paediatric Vaccine Market Share by Type
Table Middle East and Africa Paediatric Vaccine Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Paediatric Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Paediatric Vaccine Market Share by Application
Table Middle East and Africa Paediatric Vaccine Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Paediatric Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Paediatric Vaccine Sales Market Share by Company in 2017
Table GlaxoSmithCline Company Details
Table GlaxoSmithCline Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithCline Recent Development
Table Merck Company Details
Table Merck Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bristol-Myers Squibb Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Abbott Laboratories Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table Pfizer Company Details
Table Pfizer Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novo Nordisk Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Paediatric Vaccine Value Chain
Table Typical Suppliers of Key Paediatric Vaccine Raw Material
Table Paediatric Vaccine Customers List
Table Paediatric Vaccine Sales Channels
Table Paediatric Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Veterinary Healthcare Product Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 108
    This report studies the global market size of Veterinary Healthcare Product in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Healthcare Product in these regions. This research report categorizes the global Veterinary Healthcare Product market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • Global Amiodarone Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. In 2017, the global Amiodarone market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and pro......
  • Global Sotalol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties. In 2017, the global Sotalol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Sotalol market based on company, product type, application and key regions. ......
  • Global Bisoprolol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 111
    Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth. In 2017, the global Bisoprolol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Bisoprolol market based on company, product type, application and......
  • Global Fiber Supplements Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Fiber Supplements in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements in these regions. This research report categorizes the global Fiber Supplements market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opport......
  • Global PVA Embolization Particles Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 110
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. In 2017, the global PVA Embolization Particles market size was xx million US$ and is forecast to xx million US in 202......
  • Global Fiber Supplements Powder Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 93
    This report studies the global market size of Fiber Supplements Powder in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Powder in these regions. This research report categorizes the global Fiber Supplements Powder market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, m......
  • Global Fiber Supplements Capsule Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 91
    This report studies the global market size of Fiber Supplements Capsule in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Capsule in these regions. This research report categorizes the global Fiber Supplements Capsule market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global Fiber Supplements Chewable Tablets Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 94
    This report studies the global market size of Fiber Supplements Chewable Tablets in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Chewable Tablets in these regions. This research report categorizes the global Fiber Supplements Chewable Tablets market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs